JA

Jagsonpal Pharmaceuticals LtdNSE JAGSNPHARM Stock Report

Last reporting period 31 Mar, 2024

Updated 31 Oct, 2024

Last price

Market cap $B

0.007

Micro

Exchange

XNSE - National Stock Exchange Of India

View Section: Price ratios

Jagsonpal Statements

JA

Data from Jagsonpal`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

01 Nov, 2024

Jagsonpal Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

907.2

-23.1 %

100

417.05

45.8

490.15

-26.2 %

54.2

0

230.88

26.3

429.98

-14.4 %

48.9

60.17

-62.8 %

5.2

-4.43

-0.5

50.08

5.7

98.15

-51.1 %

10.4

23.03

2.3

75.12

-49.8 %

8.2

2.796

26.865

2023-09-30
%

1 179.82

2.1 %

100

515.82

43.4

664

8.1 %

56.6

0

254.05

20.2

502.46

4.3 %

42.9

161.54

21.8 %

13.7

-3.71

-0.4

42.71

3.9

200.54

16.7 %

17.2

51.03

4.3

149.51

11.7 %

12.9

5.69

26.276

2023-03-31
%

1 155.91

-4.6 %

100

541.49

49.3

614.42

-17.3 %

50.7

0

274.09

23.8

481.79

-11.7 %

41.8

132.64

-32.6 %

9

-3.762

-0.4

45.551

5.1

171.91

-2.4 %

13.2

37.985

3.1

133.82

0.4 %

10.1

5.109

26.193

2022-09-30
%

1 211.3

23.5 %

100

468.6

34.6

742.6

21.9 %

65.4

0

298.6

24.7

545.8

-3.3 %

44.4

196.9

341.5 %

21

-0.4

-0.05

14.3

1.9

176.2

164.6 %

22.8

42.8

5.6

133.3

183.6 %

17.2

5.09

26.15

2022-03-31
%

980.9

-12.8 %

100

371.9

35.4

609

-12.3 %

64.6

0

292

32.3

564.5

9.4 %

66.4

44.6

-75 %

-1.8

-1.2

-0.1

23.2

0.8

66.6

-64.5 %

-1.1

19.6

0.5

47

-64.2 %

-1.6

1.79

26.2

2021-09-30
%

1 124.4

12.5 %

100

430.4

38.4

694.1

16.4 %

61.6

0

284.7

24.1

515.8

6.3 %

45.9

178.3

61.2 %

15.7

-1.7

-0.1

11

0.5

187.7

34.2 %

16.1

56.2

4.8

131.4

24.8 %

11.2

5.02

26.2

2021-03-31
%

999.4

13.6 %

100

403.4

35.1

596.1

25.3 %

64.9

0

265

26.1

485.4

19.5 %

53.5

110.6

59.6 %

11.3

-2.7

-0.3

31.9

6.2

139.9

77.3 %

17.2

34.6

5.3

105.3

61.3 %

11.9

4.01

26.25

2020-09-30
%

880

23 %

100

404.4

49.5

475.7

-4.3 %

50.5

0

274.8

27.8

406.3

-12.6 %

42.4

69.3

115.9 %

8.1

-2.5

-0.2

11.9

0.7

78.9

80.5 %

8.6

13.6

1.5

65.3

70.5 %

7.1

2.49

26.25

2020-03-31
%

715.3

-17.8 %

100

218.1

26.5

497.2

-5.6 %

73.5

0

247.6

34.3

465.1

-4 %

70.4

32.1

-23.4 %

3.1

-2.5

-0.5

14.1

2.6

43.7

-13.3 %

5.1

5.3

-0.1

38.3

-5 %

5.3

1.46

26.2

2019-09-30
%

870.4

100

343.8

38

526.6

62

0

256.2

29.8

484.7

56.6

41.9

5.4

-2.7

-0.4

11.1

1.1

50.4

6.1

10.1

1.2

40.3

4.9

1.53

26.2

View Section: Balance Sheet